US Top News and Analysis
17h ago
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
This is the summary US Top News and Analysis published in their feed. The article itself is on their site.
Read the full article at cnbc.com